NIH-funded research NIH-funded research

How maternal health affects infant gut health and growth

Official title: The effect of the maternal plasma and breastmilk metabolome on the infant gut microbiome and growth

Funded at University of Washington · NIH-10910163 · Data updated 2026-11-12

This study is looking at how the health of mothers with HIV affects their breastmilk and how that, in turn, impacts their babies' gut health and growth, with the goal of finding better ways to support these little ones in Kenya.

More Gut Microbiome research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 18, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$161,028
NIH project number5K23HD113374-02
Project IDNIH-10910163 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include infants born to mothers living with HIV, particularly those in sub-Saharan Africa.

Less likely to help

Patients who are not exposed to HIV or those outside the age range of 0-11 years may not benefit from this research.

What this research studies

This research investigates how the health of mothers living with HIV influences the composition of their breastmilk and the subsequent impact on their infants' gut microbiome and growth. By analyzing samples from mothers and their infants in Kenya, the study aims to understand the metabolic changes in breastmilk due to maternal HIV infection. The research will utilize advanced techniques like targeted metabolomics and machine learning to uncover the biological mechanisms behind growth challenges in infants exposed to HIV. This could lead to better nutritional strategies for improving health outcomes in these vulnerable children.

Why it matters

Potential benefit: If successful, this research could lead to improved breastfeeding practices and nutritional interventions that enhance growth and health in infants exposed to HIV.

How similar studies have gone: While there is ongoing research into maternal health and infant outcomes, this specific approach combining metabolomics and machine learning is relatively novel.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Hendrixson, David Taylor — University of Washington
  • Study coordinator: Hendrixson, David Taylor

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.